MicroRNAs in the ontogeny of leukemias and lymphomas

References

• Ambros V, Lee R C. Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 2004; 265: 131–158
   PubMedGoogle Scholar
• Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297
   PubMed Web of Science ®Google Scholar
• He L, Hannon G J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522–531
   PubMed Web of Science ®Google Scholar
• Plasterk R H. Micro RNAs in animal development. Cell 2006; 124: 877–881
   PubMed Web of Science ®Google Scholar
• Pasquinelli A E, Hunter S, Bracht J. MicroRNAs: a developing story. Curr Opin Genet Dev 2005; 15: 200–205
   PubMed Web of Science ®Google Scholar
• Carleton M, Cleary M A, Linsley P S. MicroRNAs and cell cycle regulation. Cell Cycle 2007; 6: 2127–2132
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J, Yeom K H, Lee S, Baek S H, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051–4060
   PubMed Web of Science ®Google Scholar
• Cai X, Hagedorn C H, Cullen B R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957–1966
   PubMed Web of Science ®Google Scholar
• Liu C G, Calin G A, Meloon B, Gamliel N, Sevignani C, Ferracin M, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004; 101: 9740–9744
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska E A, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834–838
   PubMed Web of Science ®Google Scholar
• Schmittgen T D, Jiang J, Liu Q, Yang L. A high-throughput method to monitor the expression of microRNA precursor. Nucleic Acids Res 2004; 32: 43–53
   PubMed Web of Science ®Google Scholar
• Raymond C K, Roberts B S, Garrett-Engele P, Lim L P, Johnson J M. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 2005; 11: 1737–1744
   PubMed Web of Science ®Google Scholar
• Cummins J M, He Y, Leary R J, Pagliarini R, Diaz L A, Jr, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687–3692
   PubMed Web of Science ®Google Scholar
• Nelson P T, Baldwin D A, Scearce L M, Oberholtzer J C, Tobias J W, Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 2004; 1: 155–161
   PubMed Web of Science ®Google Scholar
• Medina P P, Slack F J. MicroRNAs and cancer: an overview. Cell Cycle 2008; 7: 2485–2492
   PubMed Web of Science ®Google Scholar
• Garzon R, Croce C M. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008; 15: 352–358
   PubMed Web of Science ®Google Scholar
• Croce C M, Calin G A. MiRNAs, cancer, and stem cell division. Cell 2005; 122: 6–7
   PubMed Web of Science ®Google Scholar
• Greaves M F. Differentiation-linked leukemogenesis in lymphocytes. Science 1986; 234: 697–704
   PubMed Web of Science ®Google Scholar
• Georgantas R W, III, Hildreth R, Morisot S, Alder J, Liu C G, Heimfeld S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007; 104: 2750–2755
   PubMed Web of Science ®Google Scholar
• Chen C Z, Li L, Lodish H F, Bartel D P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83–86
   PubMed Web of Science ®Google Scholar
• Neilson J R, Zheng G X, Burge C B, Sharp P A. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007; 21: 578–589
   PubMed Web of Science ®Google Scholar
• Nakayama T, Kasprowicz D J, Yamashita M, Schubert L A, Gillard G, Kimura M, et al. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J Immunol 2002; 168: 87–94
   PubMed Web of Science ®Google Scholar
• Zhou B, Wang S, Mayr C, Bartel D P, Lodish H F. MiR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080–7085
   PubMed Web of Science ®Google Scholar
• Monticelli S, Ansel K M, Xiao C, Socci N D, Krichevsky A M, Thai T H, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005; 6: R71
   PubMed Web of Science ®Google Scholar
• Xiao C, Calado D P, Galler G, Thai T H, Patterson H C, Wang J, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146–159
   PubMed Web of Science ®Google Scholar
• Koralov S B, Muljo S A, Galler G R, Krek A, Chakraborty T, Kanellopoulou C, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860–874
   PubMed Web of Science ®Google Scholar
• Ventura A, Young A G, Winslow M M, Lintault L, Meissner A, Erkeland S J, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875–886
   PubMed Web of Science ®Google Scholar
• Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 2001; 274: 157–167
   PubMed Web of Science ®Google Scholar
• Taganov K D, Boldin M P, Chang K J, Baltimore D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481–12486
   PubMed Web of Science ®Google Scholar
• Vigorito E, Perks K L, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27: 847–859
   PubMed Web of Science ®Google Scholar
• Thai T H, Calado D P, Casola S, Ansel K M, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604–608
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Vigorito E, Clare S, Warren M V, Couttet P, Soond D R, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608–611
   PubMed Web of Science ®Google Scholar
• Xiao C, Srinivasan L, Calado D P, Patterson H C, Zhang B, Wang J, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405–414
   PubMed Web of Science ®Google Scholar
• Li Q J, Chau J, Ebert P J, Sylvester G, Min H, Liu G, et al. MiR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147–161
   PubMed Web of Science ®Google Scholar
• Mendell J T. MiRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133: 217–222
   PubMed Web of Science ®Google Scholar
• Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly M B, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 2007; 104: 19971–19976
   PubMed Web of Science ®Google Scholar
• Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, et al. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 2001; 61: 6640–6648
   PubMed Web of Science ®Google Scholar
• Burlinger L, Dohner K, Bair E, Fröhling S, Schlenk R F, Tibshirani R, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605–1616
   PubMed Web of Science ®Google Scholar
• Calin G A, Dumitru C D, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524–15529
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin G A, Fabbri M, Iorio M V, Ferracin M, Shimizu M, et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944–13949
   PubMed Web of Science ®Google Scholar
• Kitada S, Andersen J, Akar S, Zapata J M, Takayama S, Krajewski S, et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998; 91: 3379–3389
   PubMed Web of Science ®Google Scholar
• Adachi M, Tefferi A, Greipp P R, Kipps T J, Tsujimoto Y. Preferential linkage of BCL-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J Exp Med 1990; 171: 559–564
   PubMed Web of Science ®Google Scholar
• Calin G A, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik S E, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793–1801
   PubMed Web of Science ®Google Scholar
• Scaglione B J, Salerno E, Balan M, Coffman F, Landgraf P, Abbasi F, et al. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand black mouse model. Br J Haematol 2007; 139: 645–657
   PubMed Web of Science ®Google Scholar
• Raveche E S, Salerno E, Scaglione B J, Manohar V, Abbasi F, Lin Y C, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007; 109: 5079–5086
   PubMed Web of Science ®Google Scholar
• Calin G A, Cimmino A, Fabbri M, Ferracin M, Wojcik S E, Shimizu M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008; 105: 5166–5171
   PubMed Web of Science ®Google Scholar
• Fabbri M, Ivan M, Cimmino A, Negrini M, Calin G A. Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 2007; 7: 1009–1019
   PubMed Web of Science ®Google Scholar
• Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, et al. TCL1 expression in CLL is regulated by miR-29 and miR-181. Cancer Res 2006; 66: 11590–11593
   PubMed Web of Science ®Google Scholar
• Chan T O, Rittenhouse S E, Tsichlis P N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999; 68: 965–1014
   PubMed Web of Science ®Google Scholar
• Yan X J, Albesiano E, Zanesi N, Yancopoulos S, Sawyer A, Romano E, et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2006; 103: 11713–11718
   PubMed Web of Science ®Google Scholar
• Herling M, Patel K A, Khalili J, Schlette E, Kobayashi R, Medeiros L J, et al. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 2006; 20: 280–285
   PubMed Web of Science ®Google Scholar
• Marton S, Garcia M R, Robello C, Persson H, Trajtenberg F, Pritsch O, et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 2008; 22: 330–338
   PubMed Web of Science ®Google Scholar
• Eis P S, Tam W, Sun L, Chadburn A, Li Z, Gomez M F, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627–3632
   PubMed Web of Science ®Google Scholar
• Tam W, Hughes S H, Hayward W S, Besmer P. Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 2002; 76: 4275–4286
   PubMed Web of Science ®Google Scholar
• Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39: 167–169
   PubMed Web of Science ®Google Scholar
• Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen B J, et al. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 2006; 45: 147–153
   PubMed Web of Science ®Google Scholar
• Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E, et al. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 2007; 26: 3769–3776
   PubMed Web of Science ®Google Scholar
• Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103: 7024–7029
   PubMed Web of Science ®Google Scholar
• Lawrie C H, Soneji S, Marafioti T, Cooper C D, Palazzo S, Paterson J C, et al. Microrna expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156–1161
   PubMed Web of Science ®Google Scholar
• Roehle A, Hoefig K P, Repsilber D, Thorns C, Ziepert M, Wesche K O, et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 2008; 142: 732–744
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne R D, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851–862
   PubMed Web of Science ®Google Scholar
• Rai D, Karanti S, Jung I, Dahia P L, Aguiar R C. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet 2008; 181: 8–15
   PubMed Web of Science ®Google Scholar
• He L, Thomson J M, Hemann M T, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828–833
   PubMed Web of Science ®Google Scholar
• Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004; 64: 3087–3095
   PubMed Web of Science ®Google Scholar
• O'Donnell K A, Wentzel E A, Zeller K I, Dang C V, Mendell J T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839–843
   PubMed Web of Science ®Google Scholar
• Leone G, DeGregori J, Sears R, Jakoi L, Nevins J R. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387: 422–426
   PubMed Web of Science ®Google Scholar
• Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007; 67: 5699–5707
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci 2007; 98: 1914–1920
   PubMed Web of Science ®Google Scholar
• Nishimoto S, Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 2006; 7: 782–786
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007; 26: 311–320
   PubMed Web of Science ®Google Scholar
• Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balague O, et al. MicroRNA expression profiling in classical Hodgkin lymphoma. Blood 2008; 111: 2825–2832
   PubMed Web of Science ®Google Scholar
• Nie K, Gomez M, Landgraf P, Garcia J F, Liu Y, Tan L H, et al. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242–252
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula S V, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006; 203: 311–317
   PubMed Web of Science ®Google Scholar
• Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243–249
   PubMed Web of Science ®Google Scholar
• Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5: 251–262
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin G A, Liu C G, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257–2261
   PubMed Web of Science ®Google Scholar
• Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007; 26: 4148–4157
   PubMed Web of Science ®Google Scholar
• Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis M L, Nervi C, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 2005; 123: 819–831
   PubMed Web of Science ®Google Scholar
• Johnnidis J B, Harris M H, Wheeler R T, Stehling-Sun S, Lam M H, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451: 1125–1129
   PubMed Web of Science ®Google Scholar
• Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007; 129: 617–631
   PubMed Web of Science ®Google Scholar
• Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007; 9: 775–787
   PubMed Web of Science ®Google Scholar
• Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006; 103: 5078–5083
   PubMed Web of Science ®Google Scholar
• Labbaye C, Spinello I, Quaranta M T, Pelosi E, Pasquini L, Petrucci E, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 2008; 10: 788–801
   PubMed Web of Science ®Google Scholar
• Pang L, Weiss M J, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest 2005; 115: 3332–3338
   PubMed Web of Science ®Google Scholar
• Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102: 18081–18086
   PubMed Web of Science ®Google Scholar
• Bruchova H, Yoon D, Agarwal A M, Mendell J, Prchal J T. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007; 35: 1657–1667
   PubMed Web of Science ®Google Scholar
• O'Connell R M, Rao D S, Chaudhuri A A, Boldin M P, Taganov K D, Nicoll J, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585–594
   PubMed Web of Science ®Google Scholar
• Dore L C, Amigo J D, Dos Santos C O, Zhang Z, Gai X, Tobias J W, et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci USA 2008; 105: 3333–3338
   PubMed Web of Science ®Google Scholar
• O'Connell R M, Taganov K D, Boldin M P, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604–1609
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille J J, Cimino A, Costinean S, Dumitru C D, Adair B, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-{α} stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082–5089
   PubMed Web of Science ®Google Scholar
• Perry M M, Moschos S A, Williams A E, Shepherd N J, Larner-Svensson H M, Lindsay M A. Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008; 180: 5689–5698
   PubMed Web of Science ®Google Scholar
• Garzon R, Volinia S, Liu C G, Fernandez-Cymering C, Palumbo T, Pichiorri F, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008; 111: 3183–3189
   PubMed Web of Science ®Google Scholar
• Garzon R, Garofalo M, Martelli M P, Briesewitz R, Wang L, Fernandez-Cymering C, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008; 105: 3945–3950
   PubMed Web of Science ®Google Scholar
• Burnett A K. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? – an adult treater's view. Br J Haematol 2002; 118: 357–364
   PubMed Web of Science ®Google Scholar
• Marcucci G, Radmacher M D, Maharry K, Mrozek K, Ruppert A S, Paschka P, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1919–1928
   PubMed Web of Science ®Google Scholar
• Fazi F, Racanicchi S, Zardo G, Starnes L M, Mancini M, Travaglini L, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007; 12: 457–466
   PubMed Web of Science ®Google Scholar
• Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler M U, et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007; 109: 4399–4405
   PubMed Web of Science ®Google Scholar
• Bueno M J, Perez de Castro I, Gomez de Cedron M, Santos J, Calin G A, Cigudosa J C, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13: 496–506
   PubMed Web of Science ®Google Scholar
• Zanette D L, Rivadavia F, Molfetta G A, Barbuzano F G, Proto-Siqueira R, Silva W A, Jr, et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 2007; 40: 1435–1440
   PubMed Web of Science ®Google Scholar